星昊医药
(920017)
| 流通市值：22.44亿 | | | 总市值：22.68亿 |
| 流通股本：1.23亿 | | | 总股本：1.24亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 314,456,566.52 | 158,348,371.9 | 650,139,997.82 | 474,999,356.63 |
| 营业总成本 | 268,138,160.67 | 130,347,236.65 | 542,987,849.51 | 393,132,024.11 |
| 其他经营收益 | | | | |
| 营业利润 | 59,861,682 | 36,161,762.34 | 117,421,542.41 | 96,544,498.35 |
| 利润总额 | 58,129,095.7 | 36,111,762.34 | 117,937,192.91 | 96,529,766.5 |
| 净利润 | 53,240,074.09 | 31,788,942.07 | 103,044,799.11 | 86,252,958.69 |
| 每股收益 | | | | |
| 其他综合收益 | -723,739.64 | -1,172.31 | -3,828,310.05 | -4,257,248.91 |
| 综合收益总额 | 52,516,334.45 | 31,787,769.76 | 99,216,489.06 | 81,995,709.78 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,045,213,987.36 | 1,093,849,537.18 | 1,053,842,841.78 | 1,078,243,228.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 935,050,286.83 | 937,324,456.62 | 918,853,224.64 | 877,032,111.04 |
| 资产总计 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 | 1,955,275,339.27 |
| 流动负债: | | | | |
| 流动负债合计 | 225,614,409.36 | 221,288,194.97 | 202,684,876.92 | 199,521,774.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 122,253,886.82 | 124,586,132.9 | 116,499,293.33 | 120,320,201.7 |
| 负债合计 | 347,868,296.18 | 345,874,327.87 | 319,184,170.25 | 319,841,975.76 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 | 1,635,433,363.51 |
| 股东权益合计 | 1,632,395,978.01 | 1,685,299,665.93 | 1,653,511,896.17 | 1,635,433,363.51 |
| 负债和股东权益合计 | 1,980,264,274.19 | 2,031,173,993.8 | 1,972,696,066.42 | 1,955,275,339.27 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 369,954,991.74 | 190,765,342.74 | 731,361,118.45 | 540,668,659.13 |
| 经营活动现金流出小计 | 257,750,687.66 | 118,404,947.57 | 557,137,111.83 | 456,488,600.57 |
| 经营活动产生的现金流量净额 | 112,204,304.08 | 72,360,395.17 | 174,224,006.62 | 84,180,058.56 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 510,128,184.95 | 339,137,825.61 | 931,694,232.52 | 753,807,764.02 |
| 投资活动现金流出小计 | 654,283,304.78 | 451,867,523.66 | 1,105,250,889.35 | 795,520,134.34 |
| 投资活动产生的现金流量净额 | -144,155,119.83 | -112,729,698.05 | -173,556,656.83 | -41,712,370.32 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 10,571,006.94 | 0 | 39,522,340.78 | 33,118,470 |
| 筹资活动现金流出小计 | 80,101,749.3 | 58,750 | 20,500,312.6 | 19,617,111.03 |
| 筹资活动产生的现金流量净额 | -69,530,742.36 | -58,750 | 19,022,028.18 | 13,501,358.97 |
| 汇率变动对现金及现金等价物的影响 | -795,614.18 | -524,448.8 | 964,379.32 | 1,100,650.57 |
| 现金及现金等价物净增加额 | -102,277,172.29 | -40,952,501.68 | 20,653,757.29 | 57,069,697.78 |
| 期末现金及现金等价物余额 | 332,306,072.39 | 405,252,906.44 | 434,583,244.68 | 470,999,185.17 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -102,277,172.29 | - | 20,653,757.29 | - |